Qantgene

Curated by Signal

Provider of cancer screening blood test for early detection

Overview

Provider of cancer screening blood test for early detection. The company has a GRIFFIN Deep Genomics platform that combines extreme precision sequencing, software, and AI technologies to profile cell-free DNA (cfDNA) fragments for the early detection of diseases.

Key facts

Founded: 2015
Headquarters: Berkeley, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Lifecor
Wearable defibrillator
Life Sciences TechnologyPittsburgh, United States
Psivant
Developer of therapeutics for cancer and immunology disorders
Life Sciences TechnologyBoston, United States
GL Diabetes
Glucose meters and accessories
Life Sciences TechnologyDover, United States

About Qantgene

What does Qantgene do?

Provider of cancer screening blood test for early detection.

Where is Qantgene headquartered?

Qantgene is headquartered in Berkeley, United States.

When was Qantgene founded?

Qantgene was founded in 2015.

Which sector is Qantgene in?

Qantgene operates in Life Sciences Technology.

Who are Qantgene's competitors?

Companies similar to Qantgene include Lifecor, Psivant, and GL Diabetes.